In December 2019 and January 2020, Epoch Times obtained multiple official documents from Beijing City and the Inner Mongolia Autonomous Region (AR), regarding the management of bio labs.
1. December 31, 2019: The Inner Mongolia Health Commission issued the “Emergency Notice from the Inner Mongolia AR Health Commission on Effectively Strengthening the Biosafety Management of Pathogenic Microbiology Laboratories on Human Infectious Diseases.” The notice was marked “Urgent.” The notice stated that the health administrative departments and relevant units at all levels should take it as a “political positioning” issue. The health administrative departments at all levels should conduct early detection, immediate verification, prompt reporting, and proper handling of possible emergencies. The notice asked subordinate health commissions to register the first and second classes of pathogenic microbiology laboratories and conduct regular systematic reviews of those labs.
2. January 3, 2020: The General Office of the National Health Commission issued a not-to-release-to-public “Notice of the General Office of the National Health Commission on Strengthening the Management of Biological Sample Resources and Related Research Activities in the Prevention and Control of Major Emergent Infectious Diseases.” In this notice, “biological samples” was defined as blood, pharyngeal swabs, sputum, tracheal aspiration or bronchial lavage fluid, urine, and feces of patients, suspected patients, and their close contacts. The notice prohibits all institutions and individuals from publishing information about pathogen detection and experimental activities on their own.
3. January 14, 2020: The Health Commission of the Changping District, Beijing issued a not-to-release-to-public “Notice on Conducting Special Supervision and Inspection of Pathogen Microbiology Laboratories.” The notice requires good handling in the collection, transportation, use, and scientific research management of biological sample resources. It asked the first, second, and third classes of biosafety laboratories to conduct self-inspection on January 15 and 16. Another document, “Changping District Pathogen Microbiology Laboratory Biosafety Supervision Checklist” provides a set of procedures for the reception and storage of viruses.
4. January 16, 2020: The Scientific Discipline Education Division of the Beijing Hospital Management Center issued the “Emergency Notice on the Mutual Inspection of Laboratory Biosafety in Municipal Hospitals.” The notice said that the Beijing Hospital Management Center would organize a mutual biosafety inspection of 22 hospital laboratories in the city from January 17 to 21.
5. January 16, 2020: The Science and Technology Education Department of the Beijing Health Commission issued the “Notice of the Beijing Health Commission on Holding Laboratory Biosafety Training.”
6. January 16, 2020: The National Health Commission issued the “Notice of the General Office of the National Health Commission on Printing and Distributing Biosafety Guidelines for Novel Coronavirus Laboratories.” The notice was marked “urgent” and “not to be released to the public.” It emphasized “for internal use only and not allowed to be spread on the Internet.” The notice provided detailed regulations on how to extract nucleic acids from viral cultures, conduct animal infection experiments, and handle uncultivated infectious materials.
7. February 14, 2020: At a meeting of the Central Committee of the Chinese Communist Party (CCP), Xi Jinping mentioned “Biosecurity” five times and asked “to incorporate biosecurity into the national security system and to publish the ‘Biosecurity Law’ as soon as possible.”
8. From April 26 to 29, 2020: The Standing Committee of the National People’s Congress discussed “The Draft of the Biosecurity Law.”
Related postings on Chinascope: